Showing 11,721 - 11,740 results of 52,575 for search '(( 50 a decrease ) OR ( 5 ((((point decrease) OR (fold decrease))) OR (mean decrease)) ))', query time: 1.22s Refine Results
  1. 11721

    Image_1_A Shift in Myeloid Cell Phenotype via Down Regulation of Siglec-1 in Island Macrophages of Bone Marrow Is Associated With Decreased Late Erythroblasts Seen in Anemia of Cri... by Shirin Hasan (7894118)

    Published 2019
    “…There was only a marginal increase in the number of EBIMØ after burn, but, between the signatures of EBIMØ, Siglec-1 expression (MFI) was reduced by 40% in B with and a parallel 44% decrease in TBM erythrons in the BM. There were more (2.5-fold) EEBs and less LEBs (2.4-fold) per million TBM cells in B; with a corresponding decrease in Siglec-1 and Ly6G expressions in EBIMØ associated with EEB. …”
  2. 11722
  3. 11723
  4. 11724
  5. 11725
  6. 11726

    Generation of CYP5122A1 half knock-outs. by Smriti Verma (204089)

    Published 2011
    “…<p><b>A:</b> Schematic representation of replacement construct inserted into the genome with positions of primers used for confirmation marked by arrows. 5′: 5′ homologous sequence; 3′: 3′ homologous sequence; Neomycin: ORF encoding for resistance to neomycin; F2: forward primer designed in the intergenic region upstream of CYP5122A1 gene; P2: internal primer in CYP5122A1 encoding sequence that has been replaced in the replacement construct; NI: primer designed in the internal sequence of ORF for neomycin resistance; Neo: primer pair amplifying neomycin resistance ORF, 5′-Neo: Primers that amplify sequence spanning the 5′ homologous region through to the end of neomycin resistance ORF. …”
  7. 11727
  8. 11728

    Inhibition of IL-6 Signaling Pathway by Curcumin in Uterine Decidual Cells by Y. Sangeeta Devi (737137)

    Published 2015
    “…<div><p>IL-6 is a multifunctional pro-inflammatory cytokine and has been implicated in many gestational disorders including preterm birth. …”
  9. 11729

    Image_2_Monocyte HLA-DR Assessment by a Novel Point-of-Care Device Is Feasible for Early Identification of ICU Patients With Complicated Courses—A Proof-of-Principle Study.pdf by Sandra Tamulyte (5421065)

    Published 2019
    “…</p><p>Results: Depending on the HLA-DR threshold applied for stratification (≤8,000/≤5,000/≤2,000 molecules/cell), a large group of patients (85.5/68.2/40.0%) already presented with a robust decrease of HLA-DR on admission, independent of the cause for critical illness. …”
  10. 11730

    Table_1_Monocyte HLA-DR Assessment by a Novel Point-of-Care Device Is Feasible for Early Identification of ICU Patients With Complicated Courses—A Proof-of-Principle Study.xlsx by Sandra Tamulyte (5421065)

    Published 2019
    “…</p><p>Results: Depending on the HLA-DR threshold applied for stratification (≤8,000/≤5,000/≤2,000 molecules/cell), a large group of patients (85.5/68.2/40.0%) already presented with a robust decrease of HLA-DR on admission, independent of the cause for critical illness. …”
  11. 11731

    Table_2_Monocyte HLA-DR Assessment by a Novel Point-of-Care Device Is Feasible for Early Identification of ICU Patients With Complicated Courses—A Proof-of-Principle Study.xlsx by Sandra Tamulyte (5421065)

    Published 2019
    “…</p><p>Results: Depending on the HLA-DR threshold applied for stratification (≤8,000/≤5,000/≤2,000 molecules/cell), a large group of patients (85.5/68.2/40.0%) already presented with a robust decrease of HLA-DR on admission, independent of the cause for critical illness. …”
  12. 11732

    Table_3_Monocyte HLA-DR Assessment by a Novel Point-of-Care Device Is Feasible for Early Identification of ICU Patients With Complicated Courses—A Proof-of-Principle Study.xlsx by Sandra Tamulyte (5421065)

    Published 2019
    “…</p><p>Results: Depending on the HLA-DR threshold applied for stratification (≤8,000/≤5,000/≤2,000 molecules/cell), a large group of patients (85.5/68.2/40.0%) already presented with a robust decrease of HLA-DR on admission, independent of the cause for critical illness. …”
  13. 11733

    Image_1_Monocyte HLA-DR Assessment by a Novel Point-of-Care Device Is Feasible for Early Identification of ICU Patients With Complicated Courses—A Proof-of-Principle Study.pdf by Sandra Tamulyte (5421065)

    Published 2019
    “…</p><p>Results: Depending on the HLA-DR threshold applied for stratification (≤8,000/≤5,000/≤2,000 molecules/cell), a large group of patients (85.5/68.2/40.0%) already presented with a robust decrease of HLA-DR on admission, independent of the cause for critical illness. …”
  14. 11734

    Density Functional Study on Compounds to Accelerate the Electron Capture Decay of <sup>7</sup>Be by Akira Yoshida (392232)

    Published 2021
    “…Thus, the decay can be accelerated by changing the chemical or physical conditions. A previous study reported a 1.1–1.5% reduction in the half-life of <sup>7</sup>Be encapsulated in C<sub>60</sub> compared with <sup>7</sup>Be metal. …”
  15. 11735
  16. 11736
  17. 11737
  18. 11738
  19. 11739
  20. 11740